Home / Stocks / BETA
Back to all stocks
NSE · BETA

Beta Drugs Limited (BETA) Share Price

Sector: Healthcare · ISIN: INE351Y01019

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,220
of 5,047 stocks
▼ 71W▲ 101M
Peak #1,147 · 02 Oct 2026

Operating in Healthcare, Beta Drugs Limited is growing revenue modestly, commands a premium earnings multiple, and earns a healthy return on equity. Ownership as of Jun 2026.

Market Cap
2,019.83 Cr
P/E Ratio
44.38
P/B Ratio
7.52
ROE
16.95%
ROCE
17.98%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
Revenue137.49 Cr125.55 Cr93.96 Cr87.27 Cr
Net Profit19.28 Cr16.49 Cr9.05 Cr8.52 Cr
EPS16.5914.788.938.40
Operating Profit27.42 Cr24.60 Cr15.78 Cr14.91 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
59.10%
Public
40.90%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs